According to Athersys's latest financial reports the company's current revenue (TTM) is $0.08 M. In 2022 the company made a revenue of $5.32 M a decrease over the years 2021 revenue that were of $5.51 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.08 M | -98.5% |
2022 | $5.32 M | -3.45% |
2021 | $5.51 M | 285.06% |
2020 | $1.43 M | -74.04% |
2019 | $5.51 M | -76.76% |
2018 | $23.73 M | 734.93% |
2017 | $2.84 M | -82.49% |
2016 | $16.23 M | 57.68% |
2015 | $10.29 M | 3500.7% |
2014 | $0.28 M | -62.12% |
2013 | $0.75 M | -88.05% |
2012 | $6.31 M | -38.93% |
2011 | $10.34 M | 15.72% |
2010 | $8.93 M | 314.03% |
2009 | $2.15 M | -30.47% |
2008 | $3.1 M | -4.75% |
2007 | $3.26 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 116,277,400.00% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 73,121,150.00% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 35,237,400.00% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 62,949,791.15% | ๐ซ๐ท France |
Merck MRK | $60.11 B | 75,142,400.00% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.00 B | 56,257,400.00% | ๐บ๐ธ USA |
Moderna
MRNA | $6.75 B | 8,442,400.00% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | $0.37 M | 366.25% | ๐บ๐ธ USA |